💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for ARCA biopharma, Inc. (ABIO)
« Back to company indexABIO Chatter Timeline
Stock Ticker for ABIO
Most Active Tweeters for ABIO
| User | Tweets |
|---|---|
| @ACInvestorBlog | 19 |
| @Tickeron | 10 |
| @SailajaVenki | 9 |
| @pvenkiraju | 8 |
| @biostockguru | 7 |
Recent Tweets for ABIO
 |
@Tickeron $ABIO in -4.86% Downtrend, sliding for three consecutive days on December 2, 2021. View odds for this and other ind… https://t.co/GuyCBPUvWo 2:12am |
|
@Tickeron How does this make you feel? $ABIO MACD Histogram turned negative on December 2, 2021. #ARCAbiopharma #stockmarket… https://t.co/bOQaj3QRNv 12:12am |
 |
@ACI_nvestorBlog RT @ACInvestorBlog: $APDN new HOD, $ABIO should follow December 3rd 2021, 9:12pm |
|
@Tickeron What do you think of this? $ABIO Stochastic Oscillator left the oversold zone. #ARCAbiopharma #stockmarket #stock… https://t.co/393vS94wFK December 3rd 2021, 9:12pm |
 |
@MrsBlackInkEco1 My favorite scanner picks from all 5 scanners on the website atm: $ABIO hit Swings n Scalps just now $BIOL hit th… https://t.co/Hl1ubLNpac December 3rd 2021, 9:12pm |
 |
@pick1998_2 article here: https://t.co/4T3iZr5RwH $ABIO December 3rd 2021, 8:12pm |
|
@pick1998_2 $ABIO good article about heparin-induced mysterious clotting. Maybe $ABIO's rNAPc2 may be superior to heparin. Phas… https://t.co/PdEUIqilSJ December 3rd 2021, 8:12pm |
 |
@onlybios $ABIO patent means 5 min green and Red . Sell and move on before you become baggie December 3rd 2021, 7:12pm |
 |
@PatentEagle ???PATENT $ABIO Arca Biopharma received an Intention to Grant a European Patent for EP3691635, titled: METHODS AND… https://t.co/zjWKyl5a1Q December 3rd 2021, 7:12pm |
 |
@pvenkiraju RT @ACInvestorBlog: $ABIO ARCA bio Sees Topline Readout Of Trial Results From rNAPc2 In Q1'22 ----> trading below cash levels ... nearly $4… December 3rd 2021, 3:12am |
|
@pvenkiraju RT @NVXI_TRADING: $ABIO news out! Could pop to $2.88+ December 3rd 2021, 3:12am |
 |
@quantisnow $ABIO ? ARCA biopharma, Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits… https://t.co/aXMDsKAnSM December 2nd 2021, 9:12pm |
|
@pvenkiraju RT @BioStocks: $ABIO Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a Potential Treatmen… December 2nd 2021, 8:12pm |
 |
@AClnvestorbIg $ABIO ARCA bio Sees Topline Readout Of Trial Results From rNAPc2 In Q1'22 ----> trading below cash levels ... nearl… https://t.co/P51mtgzT2s December 2nd 2021, 8:12pm |
|
@AClnvestorbIg $ABIO as expected !!! ARCA biopharma Reports Completed Enrollment In Phase 2b ASPEN-COVID-19 Trial Evaluating rNAPc… https://t.co/Ocot8rXk0F December 2nd 2021, 8:12pm |
 |
@BiotechJoe21 $TLIS - Broken stock, broken company? Remains to be seen. $ABIO - Broken stock, broken company, Cow milk provide… https://t.co/4h8e4kYsYG December 2nd 2021, 6:12pm |
 |
@Dt57641474 @ACInvestorBlog Remember that low float $abio December 2nd 2021, 6:12pm |
 |
@newsfilterio ARCA Biopharma Expects Data Readout From Mid-Stage COVID-19 Trial In Q1 2022 $ABIO https://t.co/SiRbb8U5OL December 2nd 2021, 5:12pm |
|
@pvenkiraju RT @ACInvestorBlog: $ABIO as expected !!! ARCA biopharma Reports Completed Enrollment In Phase 2b ASPEN-COVID-19 Trial Evaluating rNAPc2 As… December 2nd 2021, 3:12pm |
 |
@MaisaCorp $ABIO ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2… https://t.co/NuluvdvA6W December 2nd 2021, 2:12pm |
 |
@QafarovaSelbi $ABIO ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2… https://t.co/AWQhEcs41f December 2nd 2021, 2:12pm |
 |
@mehabecapital $ABIO @ 2.27 (-4.02%) : ARCA Bio completes enrollment in mid-stage rNAPc2 trail in COVID-19 https://t.co/VgqZoVK7SV December 2nd 2021, 2:12pm |
|
@pvenkiraju RT @algobotnews: ARCA Biopharma completes enrollment in Phase 2b ASPEN COVID-19 trial $ABIO December 2nd 2021, 2:12pm |
 |
@StckPro $ABIO NEW ARTICLE : ARCA Bio completes enrollment in mid-stage rNAPc2 trail in COVID-19 https://t.co/ovGdYrLQif Get… https://t.co/kj8zFrzWXA December 2nd 2021, 2:12pm |
 |
@MarcJacksonLA $ABIO ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial… https://t.co/kgLoJAHxPv December 2nd 2021, 2:12pm |
|
@onlybios $ABIO no data until next year and they’re delayed it several times and it’s possible they delay again. Can’t trust… https://t.co/eWpS6mK1mK December 2nd 2021, 1:12pm |
 |
@SailajaVenki RT @pick1998_2: $ABIO $GRTX two cheap biotech stocks with catalysts in near term. Very limited downward risk, but huge upward potential. Lo… December 2nd 2021, 1:12pm |
|
@SailajaVenki RT @ChartMill: Although the technical rating is bad, $ABIO does present a nice setup opportunity. https://t.co/LCR6MShxok https://t.co/DDSQ… December 2nd 2021, 1:12pm |
|
@SailajaVenki RT @BiotechJoe21: /6 so fugly so good? $ABIO https://t.co/12boZoN946 December 2nd 2021, 1:12pm |
|
@SailajaVenki RT @stock_titan: $ABIO ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a… December 2nd 2021, 1:12pm |
|
@SailajaVenki RT @quantisnow: $ABIO ? ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a… December 2nd 2021, 1:12pm |
|
@SailajaVenki RT @StockNewsBot2: $ABIO ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as… December 2nd 2021, 1:12pm |
|
@SailajaVenki RT @biostockguru: $ABIO #OmicronVarient #COVID19 Trades way below cash Could see a big move here December 2nd 2021, 1:12pm |
|
@SailajaVenki RT @vtmtrading: ARCA Biopharma completes enrollment in Phase 2b ASPEN COVID-19 trial $ABIO December 2nd 2021, 1:12pm |
|
@SailajaVenki RT @RafitaArmengol: $ABIO ???It’s time!!! https://t.co/HZPecMoOfR December 2nd 2021, 1:12pm |
 |
@ACInvestorBlog $ABIO ARCA bio Sees Topline Readout Of Trial Results From rNAPc2 In Q1'22 ----> trading below cash levels ... nearl… https://t.co/CRpoH4XTLm December 2nd 2021, 1:12pm |
 |
@RafitaArmengol $ABIO ???It’s time!!! https://t.co/o7BV6Us69J https://t.co/HZPecMoOfR December 2nd 2021, 1:12pm |
 |
@NVXI_TRADING $ABIO news out! Could pop to $2.88+ December 2nd 2021, 1:12pm |
|
@ACInvestorBlog $ABIO as expected !!! ARCA biopharma Reports Completed Enrollment In Phase 2b ASPEN-COVID-19 Trial Evaluating rNAPc… https://t.co/AUcZqOtUgE December 2nd 2021, 1:12pm |
 |
@vtmtrading ARCA Biopharma completes enrollment in Phase 2b ASPEN COVID-19 trial $ABIO December 2nd 2021, 1:12pm |
 |
@biostockguru $ABIO #OmicronVarient #COVID19 Trades way below cash Could see a big move here https://t.co/yUuVoOMg46 December 2nd 2021, 1:12pm |
 |
@BioStocks $ABIO Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a Potential… https://t.co/UmZLzeQDUj December 2nd 2021, 1:12pm |
 |
@StockNewsBot2 $ABIO ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc… https://t.co/jbNaPASUkA December 2nd 2021, 1:12pm |
|
@quantisnow $ABIO ? ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAP… https://t.co/BleI4kzYnR December 2nd 2021, 1:12pm |
 |
@stock_titan $ABIO ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc… https://t.co/tqMXAF8M8f December 2nd 2021, 1:12pm |
|
@BiotechJoe21 /6 so fugly so good? $ABIO https://t.co/12boZoN946 December 2nd 2021, 5:12am |
 |
@ChartMill Although the technical rating is bad, $ABIO does present a nice setup opportunity. https://t.co/LCR6MShxok https://t.co/DDSQvsItGY December 1st 2021, 10:12pm |
 |
@69NiceBot69 RT @OptionHunt: Ticker $ABIO Unusual Volume Detected: 52.69% over average December 1st 2021, 5:12pm |
 |
@OptionHunt Ticker $ABIO Unusual Volume Detected: 52.69% over average December 1st 2021, 5:12pm |
|
@pick1998_2 $ABIO $GRTX two cheap biotech stocks with catalysts in near term. Very limited downward risk, but huge upward poten… https://t.co/pheMCq4KfH December 1st 2021, 4:12pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?